HighTower Advisors’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$608K Sell
21,099
-1,626
-7% -$36.3K ﹤0.01% 2580
2026
Q1
$386K Buy
22,725
+12,764
+128% +$274K ﹤0.01% 2945
2025
Q4
$256K Sell
9,961
-4,805
-33% -$111K ﹤0.01% 3178
2025
Q3
$318K Buy
+14,766
New +$336K ﹤0.01% 2998
2024
Q4
Sell
-11,145
Closed -$181K 4004
2024
Q3
$181K Sell
11,145
-1,657
-13% -$39.8K ﹤0.01% 3170
2024
Q2
$368K Buy
+12,802
New +$386K ﹤0.01% 2556
2024
Q1
Sell
-15,431
Closed -$563K 3909
2023
Q4
$563K Buy
15,431
+93
+0.6% +$3.12K ﹤0.01% 2232
2023
Q3
$512K Buy
+15,338
New +$579K ﹤0.01% 2223
2021
Q2
Sell
-9,862
Closed -$439K 3330
2021
Q1
$439K Buy
+9,862
New +$461K ﹤0.01% 2061

Other funds holding PGNY

HighTower Advisors's PGNY Position: Q2 2026 in Review

HighTower Advisors reduced its Progyny (PGNY) stake by 7.2% in Q2 2026, selling an estimated $36.3K and leaving 21,099 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #2580.

HighTower Advisors first reported a position in PGNY in Q1 2021 and has held it in 9 quarters since. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • HighTower Advisors held 21,099 shares of Progyny worth $608K as of Q2 2026.
  • HighTower Advisors sold 1,626 Progyny shares in Q2 2026, an estimated $36.3K.
  • Progyny made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2580 holding.
  • HighTower Advisors first reported a position in Progyny in Q1 2021 and has held it in 9 quarters since.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.